StonvexLoading…
StonvexStonvexStonvexCore line items from SNDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 |
|---|---|---|---|---|
Revenue | $238.43M | $234.72M | $177.11M | $119.19M |
Operating Income | $-54.31M | $126.19M | $124.80M | $88.08M |
Net Income | $-54.40M | $125.61M | $124.43M | $49.08M |
EPS (Diluted) | $-9.27 | $37.92 | $59.59 | $42.33 |
Total Assets | $661.27M | $728.55M | $674.18M | $678.88M |
Total Liabilities | $719.43M | $734.11M | Not available | Not available |
Cash & Equivalents | $16.91M | $78.69M | $10.67M | $14.56M |
Free Cash Flow OCF − CapEx | $-27.14M | $-39.24M | $-14.26M | $2.21M |
Shares Outstanding | 6.67M | 6.63M | 2.19M | 2.19M |